Osaic Holdings’s OncoSec Medical Incorporated ONCS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-46
| Closed | -$119 | – | 7739 |
|
|
2023
Q1 | $119 | Hold |
46
| – | – | ﹤0.01% | 7317 |
|
|
2022
Q4 | $77 | Buy |
+46
| New | +$258 | ﹤0.01% | 7123 |
|
|
2022
Q3 | – | Sell |
-3
| Closed | – | – | 7812 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 7894 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 7838 |
|
|
2021
Q4 | $0 | Sell |
3
-341
| -99% | -$11.5K | ﹤0.01% | 7876 |
|
|
2021
Q3 | $16K | Buy |
344
+136
| +65% | +$6.89K | ﹤0.01% | 5939 |
|
|
2021
Q2 | $13K | Buy |
208
+180
| +643% | +$16.3K | ﹤0.01% | 5932 |
|
|
2021
Q1 | $3K | Buy |
28
+9
| +47% | +$1.23K | ﹤0.01% | 6447 |
|
|
2020
Q4 | $2K | Buy |
19
+3
| +19% | +$320 | ﹤0.01% | 6153 |
|
|
2020
Q3 | $1K | Buy |
16
+13
| +433% | +$1.01K | ﹤0.01% | 6160 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 6566 |
|
|
2020
Q1 | $0 | Buy |
+3
| New | +$112 | ﹤0.01% | 6313 |
|
Osaic Holdings's ONCS Position: Q2 2023 in Review
Osaic Holdings sold out of OncoSec Medical Incorporated (ONCS) in Q2 2023, closing a stake of 46 shares — an estimated $119 sold.
Osaic Holdings first reported a position in ONCS in Q1 2020 and held it in 12 quarters. The position peaked at $16K in Q3 2021. 0 funds tracked by Wall St. Rank hold ONCS as of Q2 2023.
- Osaic Holdings reported no remaining OncoSec Medical Incorporated position as of Q2 2023 after selling out during the quarter.
- Osaic Holdings sold 46 OncoSec Medical Incorporated shares in Q2 2023, an estimated $119.
- Osaic Holdings first reported a position in OncoSec Medical Incorporated in Q1 2020 and held it in 12 quarters.
- Osaic Holdings's OncoSec Medical Incorporated position peaked at $16K in Q3 2021.
- 0 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2023.
Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.